Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles
- 7 August 2006
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 27 (33) , 5725-5733
- https://doi.org/10.1016/j.biomaterials.2006.07.014
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative TrialClinical Cancer Research, 2004
- Effects of low dose tamoxifen on normal breast tissue from premenopausal womenEuropean Journal Of Cancer, 2003
- The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulatorsThe Lancet Oncology, 2002
- Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability StudyJournal of Clinical Oncology, 2000
- Tamoxifen in the Treatment of Breast CancerNew England Journal of Medicine, 1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression.Breast Cancer Research and Treatment, 1997
- Age-related difference in tamoxifen dispositionClinical Pharmacology & Therapeutics, 1996
- Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary MalignanciesJNCI Journal of the National Cancer Institute, 1995